Bisphenol A and peripheral arterial disease: results from the NHANES.
about
Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?Bisphenol-A and Sleep Adequacy among Adults in the National Health and Nutrition Examination SurveysAssociation of Bisphenol A Exposure With Hypertension and Early Macrovascular Diseases in Chinese Adults: A Cross-Sectional StudyPrenatal bisphenol A exposure and maternally reported behavior in boys and girlsPeripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart StudyThe adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol AThe effects of environmental chemicals on renal functionThe influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders.A Prediction Model for the Peripheral Arterial Disease Using NHANES DataCellular mechanism of the nonmonotonic dose response of bisphenol A in rat cardiac myocytes.Impact of bisphenol a on the cardiovascular system - epidemiological and experimental evidence and molecular mechanismsBisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice.Bisphenol A exposure enhances atherosclerosis in WHHL rabbits.Human Bisphenol A Exposure and the "Diabesity Phenotype"Physiological response of cardiac tissue to bisphenol A: alterations in ventricular pressure and contractility.Low-dose bisphenol A and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts.Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts.Bisphenol A exposure and cardiac electrical conduction in excised rat hearts.Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research.Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature.Bisphenol A and Metabolic Diseases: Challenges for Occupational MedicineBisphenol A, Hypertension, and Cardiovascular Diseases: Epidemiological, Laboratory, and Clinical Trial Evidence.Low-calorie sweetener use and energy balance: Results from experimental studies in animals, and large-scale prospective studies in humans.Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits.Possible influence of the environmental pollutant bisphenol A on the cardiometabolic risk factors.Serum bisphenol A and progression of type 2 diabetic nephropathy: a 6-year prospective study.Estimating bisphenol A exposure levels using a questionnaire targeting known sources of exposure.Metabolic response to chronic bisphenol A exposure in C57bl/6n mice.Lifelong exposure to bisphenol a alters cardiac structure/function, protein expression, and DNA methylation in adult mice.Epigenetic impact of endocrine disrupting chemicals on lipid homeostasis and atherosclerosis: a pregnane X receptor-centric view.Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffsProgesterone Protects Against Bisphenol A-Induced Arrhythmias in Female Rat Cardiac Myocytes via Rapid Signaling.Obesogenic endocrine disruptors and obesity: myths and truths.Perinatal bisphenol A exposure increases atherosclerosis in adult male PXR-humanized mice.Determination of bisphenol A-glucuronide in human urine using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.Bisphenol A: Understanding the Controversy.Disruption of neonatal cardiomyocyte physiology following exposure to bisphenol-a.
P2860
Q26829866-B3C81544-BC69-4907-A400-35A9343D7018Q28384016-0AA43914-3DFC-42F5-A5EF-5A5495BF5C0FQ28386682-6EC24BEC-CC04-49F5-B275-F1BC04AF4FA1Q28389977-187E6D3A-4D31-4685-9721-88522B747813Q28396309-825D6D1B-39AC-4D23-93D4-A058A30D50BAQ28396757-327A75C9-6467-4374-B945-D916C4DC4602Q28397401-A0C68D92-7C9A-4189-A411-1EBD3B6AF8CEQ30241659-E7CD07D2-C34E-435B-A504-0CEF2A43828CQ31082510-BE8CF310-6DC9-47A3-A432-0BF15947D0A4Q33730270-4BCDD4BB-2CA8-4B0C-A176-050E4B44E343Q34086177-8DDB804A-FC2E-4A81-8D0D-BBE2E48B78D9Q34297158-DA8AA4D3-8F0F-41C3-8BD5-C031D5BAB9A5Q34380796-1838A778-4A36-44BB-977F-F6E8104238A2Q34513056-D1278AC6-BC89-4ED7-AD5B-EC8F8595882CQ35859295-20853234-F985-4D3E-84DD-71935FAC6D91Q36799534-1ACE2DF0-4034-481E-AE5D-F24C95322A7DQ37331050-E6F0127A-5D51-4E7F-B858-47094215AA34Q37698791-95624E3B-DEAD-42D1-B1FE-45C50141C938Q38176050-78A61AB7-CCFB-4B88-88EF-48C6F972BCE8Q38177864-55DC6296-A107-48AD-822D-799DC4D1BE45Q38608411-29AA0620-A246-487F-B689-9D6EAEF47C43Q38701596-AD068D7D-4AAA-4093-B1B6-6E0B36BF4F4DQ38821134-B10BE6D2-87D0-47D8-9077-0E4EA17F2117Q40252231-1AA9ABDF-4358-4603-BE61-F34D1931B741Q40521486-88A30C98-DF9D-4EF3-B771-AE31173D8A91Q41438936-5A578FB9-5673-4081-BADF-0E7D517B6876Q41619910-D3B2046A-F465-4B78-846E-A81022F519BCQ41681290-EE5A7E38-F365-4521-AC32-6AF8B14D16FDQ42712886-98C56F76-EB08-4450-AC54-E3078E19CB80Q47100840-903ECD9F-834F-4ED9-94FC-264A4CEE8FE9Q47156665-E7664AF1-E6BA-4A69-A2A3-6E892CF3F222Q47821563-38CD6FA4-0135-4F7D-A9A4-E79DF137718AQ48034695-59DBF214-E89A-4009-B76D-25CB5DCDC5B8Q50099013-C2258F73-0EF6-45D5-92F5-C4F10FF35AAEQ52666957-373DF57C-45E7-41A3-8CDF-B12B94663DE2Q52667394-372F9FAA-03E4-4895-9294-F9777BE389D1Q55525183-025F0AB1-467D-4332-AFE2-CDFD12195805
P2860
Bisphenol A and peripheral arterial disease: results from the NHANES.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bisphenol A and peripheral arterial disease: results from the NHANES.
@ast
Bisphenol A and peripheral arterial disease: results from the NHANES.
@en
type
label
Bisphenol A and peripheral arterial disease: results from the NHANES.
@ast
Bisphenol A and peripheral arterial disease: results from the NHANES.
@en
prefLabel
Bisphenol A and peripheral arterial disease: results from the NHANES.
@ast
Bisphenol A and peripheral arterial disease: results from the NHANES.
@en
P2860
P356
P1476
Bisphenol A and peripheral arterial disease: results from the NHANES
@en
P2093
Anoop Shankar
P2860
P304
P356
10.1289/EHP.1104114
P577
2012-05-29T00:00:00Z